Acne Vulgaris: Pathophysiology, Topical Retinoids, and Skincare Routine

The Pathophysiology of Acne Vulgaris

Acne vulgaris is a chronic inflammatory dermatosis of the pilosebaceous unit that affects the majority of adolescents and a significant number of adults. The pathogenesis of acne is complex, involving four primary, interrelated pathological factors that occur within the hair follicle and its associated sebaceous gland:

1. Sebum Overproduction: Under the influence of androgens (specifically dihydrotestosterone), sebaceous glands increase in size and hypersecrete sebum. This lipid-rich sebum provides a substrate for microbial colonization.
2. Follicular Hyperkeratinization: Altered keratinocyte desquamation leads to accumulation of cohesive cells within the follicular infundibulum. This forms a keratinous plug (microcomedone) that obstructs the sebum outflow.
3. Microbial Colonization: The anaerobic, sebum-rich environment of the obstructed follicle promotes the proliferation of Cutibacterium acnes (formerly Propionibacterium acnes), a commensal skin bacterium.
4. Inflammation and Immune Response: C. acnes activates toll-like receptors (specifically TLR2) on keratinocytes and macrophages, triggering the release of pro-inflammatory cytokines such as interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-alpha). Neutrophils infiltrate the site, releasing hydrolytic enzymes that rupture the follicular wall, spreading inflammatory debris into the surrounding dermis and forming papules, pustules, nodules, or cysts.

Grading Acne Severity

Clinical management is determined by the severity of the lesions, which is assessed during examination:

• Mild Acne: Dominated by non-inflammatory comedones (open comedones or “blackheads” and closed comedones or “whiteheads”) with few inflammatory papules.
• Moderate Acne: Characterized by a greater number of erythematous papules and pustules, with minimal nodular lesions.
• Severe Acne: Defined by the presence of painful, deep-seated nodules, cysts, and widespread inflammation, which carry a high risk of permanent scarring and post-inflammatory hyperpigmentation.

Topical Retinoids: The Cornerstone of Therapy

According to the guidelines of care from the American Academy of Dermatology (AAD), topical retinoids (such as tretinoin, adapalene, and tazarotene) are the foundation of acne therapy. Retinoids bind to retinoic acid receptors (RARs) within keratinocytes, normalizing follicular desquamation to prevent comedone formation, and exerting direct anti-inflammatory effects by downregulating inflammatory pathways. Adapalene is often preferred as a first-line agent due to its chemical stability and lower irritation profile. Retinoids should be applied to the entire affected area, not used as spot treatments, to prevent the formation of new microcomedones. Topical retinoids are frequently combined with benzoyl peroxide (an antimicrobial agent that does not induce bacterial resistance) or topical antibiotics to target multiple pathogenic pathways simultaneously.

💡 💡 Managing the “Retinoid Uglies”

When initiating topical retinoids, patients often experience “retinization”—characterized by dryness, redness, peeling, and a transient worsening of acne. To minimize this, advise the “sandwich method”: apply a thin layer of non-comedogenic moisturizer, wait 10 minutes, apply the retinoid, and follow with another layer of moisturizer. Patients should start with alternate-day applications, gradually building up to nightly use.

Systemic Treatments for Moderate-to-Severe Acne

When topical regimens fail or in cases of severe acne, systemic therapies are indicated. Oral tetracyclines (e.g., doxycycline, minocycline) are prescribed for their anti-inflammatory properties, but should be limited to a maximum of 3 to 4 months to prevent antibiotic resistance, and must always be paired with a topical retinoid and benzoyl peroxide. For females with hormonal flares (e.g., acne worsening along the jawline premenstrually), oral contraceptives or the androgen-receptor antagonist spironolactone can be highly effective. For severe, scarring nodulocystic acne, oral isotretinoin (a systemic retinoid) is the only treatment that targets all four pathogenic factors. Due to its severe teratogenicity, it requires strict adherence to the iPLEDGE risk management program in the United States. Patients with overlapping facial skin issues, such as seborrheic dermatitis, should have their treatments carefully balanced to avoid compounding skin barrier irritation.

Designing a Clinically Sound Skincare Routine

An effective skincare routine is essential to support medical acne treatments and maintain skin barrier integrity. Key recommendations include:

• Gentle Cleansing: Wash the face twice daily using a mild, non-soap, fragrance-free cleanser. Avoid scrubbing, which can rupture follicles and worsen inflammation.
• Non-Comedogenic Moisturizers: Ensure all moisturizers, sunscreens, and cosmetics are labeled “non-comedogenic” or “oil-free” to prevent follicular clogging.
• Sun Protection: Apply a broad-spectrum, SPF 30+ sunscreen daily, as many acne medications (especially retinoids and doxycycline) increase photosensitivity.

💡 Frequently Asked Questions (FAQ)

Q1: How long does it take to see results from a new acne treatment?
A1: Acne treatments require patience, as it takes approximately 8 to 12 weeks of consistent use to see significant improvement. This timeframe matches the natural cycle of follicular renewal and the clearance of deep-seated microcomedones.

Q2: Does eating greasy food or chocolate cause acne?
A2: While greasy foods do not directly cause acne, high-glycemic-load diets (e.g., sugary foods, refined carbohydrates) and excessive dairy consumption have been linked in clinical studies to increased IGF-1 signaling, which can stimulate sebum production and exacerbate acne.

Q3: Why is it important to use sunscreen when using topical retinoids?
A3: Topical retinoids thin the stratum corneum by promoting cell turnover, which temporarily reduces the skin’s natural barrier against ultraviolet (UV) radiation. This increases the risk of sunburn and post-inflammatory hyperpigmentation, making daily broad-spectrum sunscreen application essential.

📚 References & Sources

1. Zaenglein, A. L., et al. (2016). Guidelines of care for the management of acne vulgaris. Journal of the American Academy of Dermatology, 74(5), 945-973.
2. Thiboutot, D. M., et al. (2018). Practical management of acne for clinicians: An international consensus from the Global Alliance to Improve Outcomes in Acne. Journal of the American Academy of Dermatology, 78(2S1), S1-S33.